Ellsworth Advisors, LLC Novo Cure LTD Transaction History

Ellsworth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$130.4 - $225.58 $408,282 - $706,290	-3,131 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$124.11 - $190.17 $48,278 - $73,976	389 Added 14.19%	3,131 $413,000
Q4 2020 Feb 03, 2021	BUY	$112.16 - $174.14 $44,976 - $69,830	401 Added 17.13%	2,742 $474,000
Q3 2020 Feb 03, 2021	BUY	$58.05 - $111.31 $135,895 - $260,576	2,341 New	2,341 $261,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ellsworth Advisors, LLC with notifications on news.